Ophthalmology

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.

PPD, part of Thermo Fisher Scientific

Cell and Gene Therapy

Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies

Erin Schaller; Aidan Jones

PPD, part of Thermo Fisher Scientific

Clinical Trials Representation

Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities

Jennifer Urwongse

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Pediatric Clinical Trials

Pediatric Clinical Trials: Considerations for Enrollment and Retention

Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue

Decentralized Clinical Trials

An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World

Richie Pfeiffer

PPD, part of Thermo Fisher Scientific

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Sustainable Clinical Trials

Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models

Michael J. Cohen

PPD, part of Thermo Fisher Scientific

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

Jennifer Crager; Sandra Orset, Ph.D.

PPD, part of Thermo Fisher Scientific

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

Home Healthcare in DCTs

Enhance Patient Engagement in Decentralized Trials with Home Healthcare Solutions

Eve Kamau MSc, RN

PPD, part of Thermo Fisher Scientific

Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

Ryan Jiang; Shiho Yamanaka; Wai Hong Yuen; Eve Kamau MSc, RN

PPD, part of Thermo Fisher Scientific

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

Decentralized Clinical Trials

The Evolving Role of Remote Monitoring

PPD, part of Thermo Fisher Scientific

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

Kamilla Posselt

PPD, part of Thermo Fisher Scientific

Neurodegenerative Disease Clinical Trials

Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants

John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.

PPD, part of Thermo Fisher Scientific

Clinical Trials Adherence

Evolving Solutions to Optimize Clinical Trial Decentralization

Tim Rich; John Musaus

PPD, part of Thermo Fisher Scientific

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

Tim Rich; Meredith McCumbee; Francis Jones, Ph.D.

PPD, part of Thermo Fisher Scientific